CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial Regional Heterogeneity in the Coronary Vascular Response in Women With Chest Pain and Nonobstructive Coronary Artery Disease Cellular origin and developmental program of coronary angiogenesis Plaque Rupture, compared to Plaque Erosion, is associated with Higher Level of Pan-coronary Inflammation Primary Prevention of Sudden Cardiac Death Mechanisms of Vascular Aging, A Geroscience Perspective JACC Focus Seminar Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial

Clinical Trial4 Apr 2022

JOURNAL:Circulation. Article Link

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial

D-W Park, J-M Ahn, D-Y Kang et al. Keywords: TAVR; without an indication for long-term anticoagulation; subclinical leaflet thrombosis

Full Text PDF